Phood

Probiotic drinking yoghurts have been hit by the EU ban on probiotic marketing

Special edition: Immunity

Pre- & Probiotics market snap-shot; ban to cost €1.5bn by 2020 in EU6

By Shane STARLING

The EU’s ban on prebiotics and probiotics as marketing tools has cost the market €500m and will cost a further €1bn by 2020 according to Euromonitor International data – and that’s just drinking yoghurt. Other formats have also been hit.

“This expansion to the world's most populated country supports Raisio’s aim to open up new markets for Benecol products together with its licensing partners...

Benecol enters China

By Shane STARLING

Finnish food-agriculture giant Raisio has launched its cholesterol-lowering, plant stanol-based Benecol brand in China in a powder form via mostly medical channels in its big coastal cities.

Special edition: 25 years of functional foods

Functional Foods 2.0: Beyond the nutritional shoehorn...

By Julian Mellentin

Products such as probiotic pizza, probiotic snack bars, high-fibre chicken or fish-oil fortified yoghurt may seem bizarre, says market expert Julian Mellentin in this guest article, but since 1990 thousands of products like this have been launched – and...

Is personalised nutrition about to go public in a big way?

Looking into the food future at Food Vision 2015

Is personalised nutrition about to go public in a big way?

By Shane STARLING

Nutrigenomics – the idea of optimising nutrition via individualised and/or pooled genetic data – is one that has long promised to revolutionise how we eat – not to mention keeping us healthy and out of hospitals. Are converging technologies about to deliver...

Sign up for free for the NutraIngredients Omega-3 forum on April 8. Connect with other attendees and omega-3 experts

April 8, 14:00 CET: Experts debate hot issues in NutraIngredients omega-3 forum

Omega-3 hits €25bn but can it keep growing?

By Shane STARLING

Are omega-3 fisheries really under threat? How many functional foods have cracked omega-3 blockbuster status? How is the sector recovering from the ‘Brasky effect’? How are developing markets developing? How is the latest research influencing regulation?...

EU harmonisation needed to break botanical deadlock

Special edition: Botanicals

What will it take to break the botanicals deadlock?

By Annie Harrison-Dunn

Two pending European Courts of Justice (ECJ) cases and the prospect of a unified pan-EU list of safe botanicals hold the potential to break the current deadlock around botanicals, according to experts. 

6 years of hurt: Probiotic heavyweights debate the EU’s health claim blockade

Yakult at Probiota 2015: “We want to be clear that before we invest we need to have some dialogue with EFSA...”

6 years of hurt: Probiotic heavyweights debate the EU’s health claim blockade

By Shane STARLING

Yakult and leading academics expressed frustration at what they see as unfair and opaque scientific requirements around probiotic health claims in the European Union – but how much is industry to blame and could social media be a data-sharing saviour?

SATIN chief: “...even if not combined with another effective mono-therapy it could become a very powerful tool.”

"We hope to develop a pill for fexaramine within 24 to 36 months to try in humans."

Satiety pill shows metabolic syndrome potential: Mice study

By Shane STARLING

The mainstream press has latched onto a mouse study that shows a bile-controlling, gut restricted pharma intervention can mimic food intake and therefore potentially be an obesity beater. But could it pass clinical inspection? One weight loss researcher...

BASF sells Norwegian omega-3 business to US firm

BASF sells Norwegian omega-3 business to US firm

By Shane STARLING

BASF has sold its Norwegian, “natural fish oils, medium-concentrated omega-3s, and customised bottled fish oil” plant to Pennsylvania firm Marine Ingredients for an undisclosed sum as the German ingredients and chemicals giant switches its focus to high-end...

Mellentin:

Special edition: Functional foods

Phood booed: Why big pharma fails at functional food

By Julian Mellentin

Faced with mounting difficulties in their drug businesses, many pharmaceutical manufacturers are looking at getting into functional foods and beverages, notes food marketing expert, Julian Mellentin in this guest article.

NPN: “Herbs at the moment are the biggest problem but not the only problem.

‘Elegant’: Dutch group seeks traditional health claims regulation

By Shane STARLING

A Dutch healthy foods and supplements association has proposed a traditional claims regulation or amendment to EU health claim laws it says would ‘elegantly’ solve the ongoing and stalled imbroglio about how traditional food use data can back claims.

“A congress like this is a stimulus for organisations to reassess recommendations...”

Academic: "Anybody who thinks the world’s malnutrition problems are going to be solved without industry is dreaming."

Time for a vitamin E intake rethink? Emerging data builds argument

By Shane Starling from the 3rd World Congress of Public Health Nutrition in Las Palmas, Gran Canaria

Emerging research linking vitamin E deficiency with increased risk of Alzheimer’s, miscarriages and fatty liver disease can contribute to an ongoing debate around recommended intakes, a nutrition congress was told yesterday.

Author response: On the bending of EU botanical laws and meanings

By Bert Schwitters

Last week NutraIngredients published a guest article by author Bert Schwitters about the EU nutrition and health claims regulation (NHCR) that discussed the status of botanicals and associated claims in the European Union. Schwitters was not happy with...

ANSES has received 1500 adverse event reports since 2010

Report card: French laud nutrivigilance success

By Shane STARLING

France’s nutrivigilence work – launched in 2010 to ensure safety in food supplements and some foodstuffs – has improved the quality of the food supply, the country’s food safety agency has said.

Medical Brands markets medical devices like cranberry-based I-Say in the EU...it targets women's urinary tract infection (UTI) issues

Industry voice: In defense of nutritional medical devices in the EU

By Maikel Hendriks, CEO of Medical Brands

Since 2008 the severity of the EU’s health claim laws has seen many firms seek other routes to back claims – the EU’s medical devices legal avenue being one of them. Amsterdam-based Maikel Hendriks, the CEO of Medical Brands, examines the controversial,...

Firms like Nexira promote nutrient-health links at shows like HI-Japan, but they do not always make it onto products as claims

"We aren’t going to wake up one day and everything will be crystal clear; there’s going to be some trial and error going through it.”

Godsend or Godzilla? What will Japan’s new health claims system look like?

By RJ Whitehead & Shane Starling at Health Ingredients-Japan in Tokyo

Japan will implement a new health claims system that is set to supersede its strict FOSHU regime in April 2015 – just six months away – but what form will it take and will it meet its deadline?

Follow us

Products

View more

Webinars